Clinical Trial

Trial Protocol ID USOR 23062_56021927PCR3020_LIBERTAS

Trial Description

A Phase 3, Open-label, Randomized, Prospective Study of Apalutamide with Continued Versus Intermittent Androgen-Deprivation Therapy (ADT) following PSA Response in Participants with Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Vinni Juneja, M.D.

Disease Types

Sponsor

  • JANSSEN

ClinicalTrials.gov NCT ID

  • NCT05884398